Effects of Dialysis Type on Survival in Patients with End-Stage Kidney Disease. Ann Intern Med. 2005;143:I-17. doi: 10.7326/0003-4819-143-3-200508020-00001
Download citation file:
Published: Ann Intern Med. 2005;143(3):I-17.
Kidneys are the organs that filter out waste products and water from the blood. When kidneys fail to function, dialysis can clean waste products artificially. There are 2 forms of dialysis: a kidney machine that filters the blood (hemodialysis) and an exchange process that uses the lining of the inside of the abdomen as a filter (peritoneal dialysis). In peritoneal dialysis, a cleansing liquid drains from a bag into the abdomen through a tube. Waste products and water pass through the lining of the abdomen into the liquid. The waste-filled liquid is then drained from the abdomen.
Doctors may recommend either type of dialysis for patients with end-stage kidney disease. Some studies suggest, however, that patients who get peritoneal dialysis differ in several ways from those who get hemodialysis. Also, there is controversy about which type of dialysis offers a survival advantage.
To compare the risk for death with peritoneal dialysis versus hemodialysis.
1041 adults with newly diagnosed end-stage kidney disease (274 receiving peritoneal dialysis and 767 receiving hemodialysis). Their average age was about 55 years.
During October 1995 to June 1998, the researchers recruited patients with newly diagnosed kidney failure from 81 dialysis clinics in 19 states. Patients answered questions about their health behaviors, medical history, and social support and had multiple laboratory tests. The researchers then followed outcomes of patients for up to 7 years.
Twenty-five percent of the patients receiving peritoneal dialysis and 5% of those receiving hemodialysis switched to the other dialysis type during follow-up. Patients starting treatment with peritoneal dialysis appeared healthier than did those starting treatment with hemodialysis. Also, more of them were high school graduates, were married, and were employed. Analyses that adjusted for these differences found statistically significantly higher risks for death among patients receiving peritoneal dialysis compared with those receiving hemodialysis during the second, but not first, year of dialysis.
The study was not a randomized trial.
Although patients with end-stage kidney disease who get peritoneal dialysis may be healthier than other patients when they start treatment, they frequently switch to hemodialysis. Continuing peritoneal dialysis over time might be associated with increased risk for death.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Nephrology, Renal Replacement Therapy, Chronic Kidney Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only